Developer docs
API playgroundTry for free, no card

Search company profiles

Kvantify

Full company profile

uuid0000ijz

Namestring
Kvantify
Legal namestring
Kvantify ApS
Websiteurl
kvantify.dk
Company typeenum
Private
Founded yearint
2022
Descriptiontext

Kvantify ApS is a Danish quantum computing software company founded in 2022 and headquartered in Copenhagen, with roots in Aarhus. The company develops hybrid quantum-classical computing software that distributes molecular simulation calculations across quantum processors and classical CPU/GPU architectures to solve computationally intensive problems in chemistry and biology, primarily targeting pharmaceutical drug discovery and life sciences applications.

The company's flagship product is Qrunch, a quantum computing software platform launched in November 2025 at the SC25 conference. Qrunch enables domain scientists to build and run quantum chemistry algorithms on real quantum hardware without requiring specialized quantum expertise, addressing enterprise adoption barriers of accessibility, scalability, and cost. The platform demonstrates 3-4x improvement in problem-size capacity using up to 80 qubits, supports full-chip utilization on quantum processors, and is natively integrated with Amazon Braket, IQM Quantum Computers, and Equal1 silicon quantum processors. Research collaborations with Aarhus University, Aalborg University, and Atom Computing through the funded EarlyBIRDD (DKK 30M) and ODAQS (DKK 17.4M) projects extend the company's technical footprint into drug-protein binding prediction and reinforcement learning-based drug discovery.

Kvantify generates revenue through software licensing and platform access fees for the Qrunch platform, delivered as a cloud-based service integrated with quantum hardware marketplaces. The go-to-market combines enterprise field sales targeting pharmaceutical and life sciences companies with a product-led motion through Amazon Braket, supplemented by regional channel partners covering Japan (TMK SOYAKU) and Southeast Asia and the Middle East (Molecular Solutions Software). The company has raised approximately €22.4M in disclosed funding across multiple rounds from Dreamcraft Ventures, Lundbeckfonden BioCapital, EIFO, the European Innovation Council Fund, and Delphinus Venture Capital. Novonesis is the publicly named enterprise customer, using Qrunch for enzyme optimization and molecular modeling.

Short descriptiontext

Kvantify is a Danish quantum computing software company that develops the Qrunch hybrid quantum-classical platform for molecular simulation, primarily serving pharmaceutical, biotechnology, and life sciences researchers working on drug discovery and enzyme optimization.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersCopenhagen, Denmark
HQ citystring
Copenhagen
HQ countrystring
Denmark
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
quantum computing software, molecular simulation software, drug discovery platform, hybrid quantum-classical computing, computational chemistry tools
Industry4 codes
PRIMARYHDAGANAC
Hybrid Algorithm Frameworks & Libraries (VQE/QAOA/QML Tooling)
Hardware, Technology & Telecom/Quantum Computing/Hybrid Quantum-Classical Systems (Integration with Traditional Computing)
SECONDARYHDAGACAB
Quantum Development Frameworks & Libraries
Hardware, Technology & Telecom/Quantum Computing/Quantum Software, SDKs & Development Tools
SECONDARYHDAGACAA
Quantum Programming Languages & SDKs
Hardware, Technology & Telecom/Quantum Computing/Quantum Software, SDKs & Development Tools
SECONDARYHDAGAMAK
Hybrid Quantum-Classical Computing & Systems Integration Research
Hardware, Technology & Telecom/Quantum Computing/Quantum Research & Development (Academic and Industry Research)
NAICS code2 codes
  • Software Publishers5132
  • Computer Systems Design and Related Services54151
SIC code1 code
  • Services-Computer Programming Services7371
Product category
Quantum Computing Software for Life Sciences
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Qrunch Platform Licensing
TypeSubscription Recurring
Description

Software platform delivered as a cloud-based service integrated with quantum hardware providers (AWS Braket, IQM). Revenue likely generated through platform access fees and usage-based charges for quantum computing resources.

quantumcomputingreport.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1Qrunch
Description

Quantum computing software platform for chemical and biological research that enables quantum chemistry calculations on real quantum hardware. Launched November 2025, integrates with Amazon Braket and IQM Quantum Computers.

kvantify.com
Core offering1 text field

Kvantify develops hybrid quantum-classical software that runs on both quantum computers and classical CPU/GPU architectures to solve complex molecular discovery problems in chemistry and biology. Its flagship product, Qrunch, is a cloud-delivered platform that enables domain scientists to build and run quantum chemistry algorithms without specialized quantum expertise, integrating with quantum hardware providers such as Amazon Braket and IQM Quantum Computers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 3-4× improvement in problem-size capacity using up to 80 qubits
+1 more record
Product overview1 text field

Kvantify offers a unified quantum-classical computing platform for molecular discovery in life sciences. The flagship product is Qrunch, a quantum computing software platform launched in November 2025, which enables quantum chemistry calculations on real quantum hardware. Qrunch integrates with cloud platforms like Amazon Braket and IQM Quantum Computers, and is designed to make quantum computing accessible for chemical and biological research by enabling domain scientists to build quantum algorithms without specialized quantum expertise. The technology couples quantum speed and accuracy with classical computing power to solve challenging problems in chemistry and biology for drug discovery.

Product and service2 records
1Qrunch
CategoryQuantum Computing Software Platform
Description

Quantum computing software platform that enables advanced quantum chemistry calculations on real quantum hardware for chemical and biological research. It allows domain scientists to build and run quantum algorithms without requiring quantum expertise, integrates with Amazon Braket and IQM Quantum Computers, and is validated to deliver 3-4× improvement in problem-size capacity using up to 80 qubits with full-chip utilization.

2Hybrid Quantum-Classical Computing Platform
CategoryQuantum Computing Software Platform
Description

Foundational technology that couples quantum computing accuracy and speed with classical computing power to cover large chemical and biological spaces. Designed to distribute calculations across appropriate quantum or classical compute architecture in high-performance computing environments for drug discovery and molecular design applications.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-20
Description

Strategic alliance to deliver integrated quantum computing solutions for life sciences. Combines Equal1's scalable silicon quantum hardware with Kvantify's quantum algorithms for molecular modeling and biochemical calculations. Joint cross-functional working group established to evaluate customer projects and align technical roadmaps.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-16
Description

EarlyBIRDD project collaboration funded with DKK 30 million from Innovation Fund Denmark. Project aims to develop quantum computing methods for drug discovery including predicting drug-protein binding.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-06
Description

Lead institution for ODAQS project (DKK 17.4M funding from Innovation Fund Denmark) and EarlyBIRDD project. Collaboration aims to develop quantum software tools for drug discovery and strengthen Denmark's quantum ecosystem.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-06
Description

Research partner in ODAQS project funded with DKK 17.4M from Innovation Fund Denmark (2026-2029). Project develops quantum software stack using reinforcement learning for drug discovery.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-11-19
Description

European quantum hardware provider partnership for Qrunch platform launch. Integration connects Kvantify's molecular modeling algorithms with IQM's quantum processors in the European quantum ecosystem.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-02-25
Description

Qrunch software made available on Amazon Braket, enabling advanced quantum chemistry calculations on NISQ devices. Integration simplifies building and running hybrid quantum algorithms for chemists.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Xanadu offers PennyLane, a widely adopted quantum software framework with cloud access to multiple quantum hardware backends, competing with Qrunch for developer mindshare and enterprise molecular simulation workloads.

TypeDirect peer
Description

Classiq builds a hybrid quantum-classical software development platform that abstracts low-level quantum programming, directly competing with Kvantify's Qrunch platform for enterprise users wanting hardware-agnostic quantum algorithm development.

TypeDirect peer
Description

QC Ware develops enterprise quantum and quantum-inspired software with a strong focus on chemistry and materials science applications, making it a directly comparable peer to Kvantify in life-sciences and pharma use cases.

TypeBroad incumbent
Description

Quantinuum is a full-stack trapped-ion quantum computing provider combining proprietary hardware with a software platform (InQuanto) for chemistry applications, directly overlapping with Kvantify's drug-discovery value proposition at greater scale.

TypeDirect peer
Description

Strangeworks provides a quantum computing software platform that aggregates multiple hardware backends and offers enterprise tools for algorithm development, directly comparable to Kvantify's hardware-agnostic Qrunch approach.

TypeDirect peer
Description

Zapata AI (formerly Zapata Computing) builds enterprise quantum and quantum-inspired software for chemistry, optimization, and ML, directly overlapping with Kvantify's molecular simulation and drug-discovery focus.

TypeEmerging player
Description

Multiverse Computing delivers quantum and quantum-inspired software for finance and industry; while its primary vertical is finance, its hybrid quantum-classical platform architecture and European footprint make it an adjacent comparable to Kvantify.

TypeBroad incumbent
Description

Pasqal is a neutral-atom quantum hardware provider that has built its own chemistry-oriented software tools (QUBEC), positioning it as a hybrid hardware-software competitor pursuing life-sciences use cases similar to Kvantify.

TypeBroad incumbent
Description

IBM Quantum operates the largest quantum hardware fleet globally with Qiskit as its open-source software SDK, representing the dominant incumbent against which Kvantify's hardware-agnostic framework must differentiate.

10Quirks AI (Quantum-Selected)
TypeRegional player
Description

Quna is a quantum computing services and software company based in Europe with chemistry and optimization focus; its regional overlap and life-sciences orientation make it a relevant peer for Kvantify's European quantum ecosystem positioning.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors12 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Kvantify

Quantum Computing Software for Life Scienceskvantify.dk

Kvantify is a Danish quantum computing software company that develops the Qrunch hybrid quantum-classical platform for molecular simulation, primarily serving pharmaceutical, biotechnology, and life sciences researchers working on drug discovery and enzyme optimization.

What Kvantify does

Kvantify ApS is a Danish quantum computing software company founded in 2022 and headquartered in Copenhagen, with roots in Aarhus. The company develops hybrid quantum-classical computing software that distributes molecular simulation calculations across quantum processors and classical CPU/GPU architectures to solve computationally intensive problems in chemistry and biology, primarily targeting pharmaceutical drug discovery and life sciences applications.

The company's flagship product is Qrunch, a quantum computing software platform launched in November 2025 at the SC25 conference. Qrunch enables domain scientists to build and run quantum chemistry algorithms on real quantum hardware without requiring specialized quantum expertise, addressing enterprise adoption barriers of accessibility, scalability, and cost. The platform demonstrates 3-4x improvement in problem-size capacity using up to 80 qubits, supports full-chip utilization on quantum processors, and is natively integrated with Amazon Braket, IQM Quantum Computers, and Equal1 silicon quantum processors. Research collaborations with Aarhus University, Aalborg University, and Atom Computing through the funded EarlyBIRDD (DKK 30M) and ODAQS (DKK 17.4M) projects extend the company's technical footprint into drug-protein binding prediction and reinforcement learning-based drug discovery.

Kvantify generates revenue through software licensing and platform access fees for the Qrunch platform, delivered as a cloud-based service integrated with quantum hardware marketplaces. The go-to-market combines enterprise field sales targeting pharmaceutical and life sciences companies with a product-led motion through Amazon Braket, supplemented by regional channel partners covering Japan (TMK SOYAKU) and Southeast Asia and the Middle East (Molecular Solutions Software). The company has raised approximately €22.4M in disclosed funding across multiple rounds from Dreamcraft Ventures, Lundbeckfonden BioCapital, EIFO, the European Innovation Council Fund, and Delphinus Venture Capital. Novonesis is the publicly named enterprise customer, using Qrunch for enzyme optimization and molecular modeling.

Kvantify firmographics

Firmographics
Name
Kvantify
Legal name
Kvantify ApS
Website
https://kvantify.dk
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
51–100 employees
Short description
Kvantify is a Danish quantum computing software company that develops the Qrunch hybrid quantum-classical platform for molecular simulation, primarily serving pharmaceutical, biotechnology, and life sciences researchers working on drug discovery and enzyme optimization.
Ownership category
akta.pro rank

Kvantify industry classification

Industry
Product category
Quantum Computing Software for Life Sciences
NAICS
Software Publishers (5132), Computer Systems Design and Related Services (54151)
SIC
Services-Computer Programming Services (7371)
akta.pro industry
PRIMARYHDAGANAC
Hybrid Algorithm Frameworks & Libraries (VQE/QAOA/QML Tooling)
Hardware, Technology & Telecom/Quantum Computing/Hybrid Quantum-Classical Systems (Integration with Traditional Computing)
SECONDARYHDAGACAB
Quantum Development Frameworks & Libraries
Hardware, Technology & Telecom/Quantum Computing/Quantum Software, SDKs & Development Tools
SECONDARYHDAGACAA
Quantum Programming Languages & SDKs
Hardware, Technology & Telecom/Quantum Computing/Quantum Software, SDKs & Development Tools
SECONDARYHDAGAMAK
Hybrid Quantum-Classical Computing & Systems Integration Research
Hardware, Technology & Telecom/Quantum Computing/Quantum Research & Development (Academic and Industry Research)

Keywords

  • Quantum computing software
  • Molecular simulation software
  • Drug discovery platform
  • Hybrid quantum-classical computing
  • Computational chemistry tools

Where Kvantify is headquartered

Location

Headquarters

HQ city
Copenhagen
HQ country
Denmark
HQ region
Europe

Offices2 records

Markets served

Kvantify business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. Qrunch Platform Licensing: Software platform delivered as a cloud-based service integrated with quantum hardware providers (AWS Braket, IQM). Revenue likely generated through platform access fees and usage-based charges for quantum computing resources.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Kvantify product offering

Product offering

Core offering

Kvantify develops hybrid quantum-classical software that runs on both quantum computers and classical CPU/GPU architectures to solve complex molecular discovery problems in chemistry and biology. Its flagship product, Qrunch, is a cloud-delivered platform that enables domain scientists to build and run quantum chemistry algorithms without specialized quantum expertise, integrating with quantum hardware providers such as Amazon Braket and IQM Quantum Computers.

Product overview

Kvantify offers a unified quantum-classical computing platform for molecular discovery in life sciences. The flagship product is Qrunch, a quantum computing software platform launched in November 2025, which enables quantum chemistry calculations on real quantum hardware. Qrunch integrates with cloud platforms like Amazon Braket and IQM Quantum Computers, and is designed to make quantum computing accessible for chemical and biological research by enabling domain scientists to build quantum algorithms without specialized quantum expertise. The technology couples quantum speed and accuracy with classical computing power to solve challenging problems in chemistry and biology for drug discovery.

Differentiator

Problem solved

Functional benefit

Brands

  • Qrunch: Quantum computing software platform for chemical and biological research that enables quantum chemistry calculations on real quantum hardware. Launched November 2025, integrates with Amazon Braket and IQM Quantum Computers.

Products and services

  • Qrunch Quantum computing software platform that enables advanced quantum chemistry calculations on real quantum hardware for chemical and biological research. It allows domain scientists to build and run quantum algorithms without requiring quantum expertise, integrates with Amazon Braket and IQM Quantum Computers, and is validated to deliver 3-4× improvement in problem-size capacity using up to 80 qubits with full-chip utilization.
  • Hybrid Quantum-Classical Computing Platform Foundational technology that couples quantum computing accuracy and speed with classical computing power to cover large chemical and biological spaces. Designed to distribute calculations across appropriate quantum or classical compute architecture in high-performance computing environments for drug discovery and molecular design applications.

Quantifiable outcome

  • 3-4× improvement in problem-size capacity using up to 80 qubits
  • +1 more outcomes

Companies that use Kvantify

Customer profile

Named customers3 records

Segments2 records

Ideal customer profiles2 records

Kvantify technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability3 records

Feature4 records

Kvantify partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core.

  • Equal1coreStrategic or Co-development Partner · 20 April 2026Strategic alliance to deliver integrated quantum computing solutions for life sciences. Combines Equal1's scalable silicon quantum hardware with Kvantify's quantum algorithms for molecular modeling and biochemical calculations. Joint cross-functional working group established to evaluate customer projects and align technical roadmaps.
  • Atom ComputingcoreStrategic or Co-development Partner · 16 March 2026EarlyBIRDD project collaboration funded with DKK 30 million from Innovation Fund Denmark. Project aims to develop quantum computing methods for drug discovery including predicting drug-protein binding.
  • Aarhus UniversitycoreStrategic or Co-development Partner · 6 March 2026Lead institution for ODAQS project (DKK 17.4M funding from Innovation Fund Denmark) and EarlyBIRDD project. Collaboration aims to develop quantum software tools for drug discovery and strengthen Denmark's quantum ecosystem.
  • Aalborg UniversitycoreStrategic or Co-development Partner · 6 March 2026Research partner in ODAQS project funded with DKK 17.4M from Innovation Fund Denmark (2026-2029). Project develops quantum software stack using reinforcement learning for drug discovery.
  • IQM Quantum ComputerscoreTechnology or Integration · 19 November 2025European quantum hardware provider partnership for Qrunch platform launch. Integration connects Kvantify's molecular modeling algorithms with IQM's quantum processors in the European quantum ecosystem.
  • AWS / Amazon BraketcoreTechnology or Integration · 25 February 2025Qrunch software made available on Amazon Braket, enabling advanced quantum chemistry calculations on NISQ devices. Integration simplifies building and running hybrid quantum algorithms for chemists.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Kvantify competitors and assessment

Company assessment

Direct peers

  • Xanadu: Xanadu offers PennyLane, a widely adopted quantum software framework with cloud access to multiple quantum hardware backends, competing with Qrunch for developer mindshare and enterprise molecular simulation workloads.
  • Classiq Technologies: Classiq builds a hybrid quantum-classical software development platform that abstracts low-level quantum programming, directly competing with Kvantify's Qrunch platform for enterprise users wanting hardware-agnostic quantum algorithm development.
  • QC Ware: QC Ware develops enterprise quantum and quantum-inspired software with a strong focus on chemistry and materials science applications, making it a directly comparable peer to Kvantify in life-sciences and pharma use cases.
  • Strangeworks: Strangeworks provides a quantum computing software platform that aggregates multiple hardware backends and offers enterprise tools for algorithm development, directly comparable to Kvantify's hardware-agnostic Qrunch approach.
  • Zapata AI: Zapata AI (formerly Zapata Computing) builds enterprise quantum and quantum-inspired software for chemistry, optimization, and ML, directly overlapping with Kvantify's molecular simulation and drug-discovery focus.

Broad incumbents

  • Quantinuum: Quantinuum is a full-stack trapped-ion quantum computing provider combining proprietary hardware with a software platform (InQuanto) for chemistry applications, directly overlapping with Kvantify's drug-discovery value proposition at greater scale.
  • Pasqal: Pasqal is a neutral-atom quantum hardware provider that has built its own chemistry-oriented software tools (QUBEC), positioning it as a hybrid hardware-software competitor pursuing life-sciences use cases similar to Kvantify.
  • IBM Quantum: IBM Quantum operates the largest quantum hardware fleet globally with Qiskit as its open-source software SDK, representing the dominant incumbent against which Kvantify's hardware-agnostic framework must differentiate.

Emerging players

  • Multiverse Computing: Multiverse Computing delivers quantum and quantum-inspired software for finance and industry; while its primary vertical is finance, its hybrid quantum-classical platform architecture and European footprint make it an adjacent comparable to Kvantify.

Regional players

  • Quirks AI (Quantum-Selected): Quna is a quantum computing services and software company based in Europe with chemistry and optimization focus; its regional overlap and life-sciences orientation make it a relevant peer for Kvantify's European quantum ecosystem positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Kvantify social profiles

Digital presence

Kvantify financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Kvantify leadership team

Management profile

Number of profiles

Profiles2 records

Kvantify funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors12 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Kvantify M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kvantify

What does Kvantify do?

Kvantify develops hybrid quantum-classical software that runs on both quantum computers and classical CPU/GPU architectures to solve complex molecular discovery problems in chemistry and biology. Its flagship product, Qrunch, is a cloud-delivered platform that enables domain scientists to build and run quantum chemistry algorithms without specialized quantum expertise, integrating with quantum hardware providers such as Amazon Braket and IQM Quantum Computers.

Is Kvantify a public or private company?

Kvantify is a private company. It is classified as venture growth investor backed and is currently operating.

When was Kvantify founded?

Kvantify was founded in 2022. It employs 51 to 100 people.

Where is Kvantify based?

Kvantify is headquartered in Copenhagen, Denmark, in the Europe region.

How does Kvantify make money?

One revenue line is on record: qrunch Platform Licensing.

Who are Kvantify's main competitors?

Direct peers on record are Xanadu, Classiq Technologies, QC Ware, Strangeworks and Zapata AI. Broad incumbents are Quantinuum, Pasqal and IBM Quantum. Multiverse Computing is listed as an emerging player. Quirks AI (Quantum-Selected) is listed as a regional player.

Does Kvantify have an API?

No public API is recorded for Kvantify.

What industry is Kvantify in?

Kvantify's product category is Quantum Computing Software for Life Sciences. Its primary akta.pro industry code is HDAGANAC, Hybrid Algorithm Frameworks & Libraries (VQE/QAOA/QML Tooling), with a secondary code of HDAGACAB, Quantum Development Frameworks & Libraries. Its NAICS code is 5132 and its SIC code is 7371.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
HpcwireSince 1987 – Covering the Fastest Computers in the World and the People Who Run ThemKvantify and Equal1 have announced a strategic alliance to deliver integrated quantum computing solutions for life sciences applications including drug discovery, advanced chemistry, and biotechnical science. The partnership combines Equal1's scalable quantum hardware with Kvantify's quantum algorithms, enabling molecular modeling and biochemical calculations beyond the reach of classical systems. A joint cross-functional working group has been established to evaluate customer projects, align technical roadmaps, and coordinate delivery of integrated solutions.Quantum Computing ReportEqual1 and Kvantify Establish Partnership for Life Sciences Quantum SimulationsEqual1, a developer of silicon-based quantum hardware, and Kvantify, a quantum software provider specializing in chemistry simulations, have formed a strategic alliance to advance quantum applications in drug discovery, biotechnology, and advanced chemistry. The partnership integrates Equal1's silicon quantum processors with Kvantify's molecular modeling algorithms and establishes a joint working group to coordinate hardware-software roadmaps and evaluate prospective industrial projects. This agreement builds on Equal1's prior technical partnerships with Bull (Atos Group) and Q-CTRL, adding a dedicated application layer for chemical simulations to existing HPC integration and autonomous hardware operation infrastructure.ItbriefKvantify hires Dr David Siebert to lead global business developmentKvantify, a Copenhagen-based Danish quantum software company, has appointed Dr. David Siebert as SVP and Global Head of Business Development as part of a wider expansion of its commercial team targeting industrial users in life sciences markets. Siebert brings over seven years of international scientific business development experience from Syngene, Schrödinger, and Avantor, and will lead efforts to build partnerships and identify use cases for hybrid quantum-classical software in drug discovery. The company is also extending its international reach through external partners including Molecular Solutions Software covering South East Asia and the Middle East from India, and TMK SOYAKU covering Japan.IqmKvantify is Scaling Quantum Chemistry on IQM ResonanceKvantify successfully ran its FAST-VQE quantum chemistry algorithm on 50 qubits using IQM Emerald, one of the most powerful commercially available quantum computers, demonstrating calculations that exceed classical computing capabilities. The company achieved approximately 30 kcal/mol energy improvement using a greedy optimization strategy compared to full-parameter methods, while also proving that current quantum hardware consistently outperforms random gate selection baselines for convergence speed. These results illustrate that quantum devices are enabling chemically relevant simulations that were out of reach just a year ago, though classical optimization increasingly becomes the bottleneck as hardware scales.ThequantuminsiderKvantify, Atom Computing and Aarhus University Launch Quantum Drug Discovery ProjectKvantify, Atom Computing, and Aarhus University launched the EarlyBIRDD project, funded with DKK 30 million from Innovation Fund Denmark, to develop quantum computing methods for drug discovery. The project aims to improve molecular simulations, including predicting drug-protein binding, with potential to significantly reduce pharmaceutical R&D costs and timelines.HpcwireSince 1987 – Covering the Fastest Computers in the World and the People Who Run ThemDanish quantum software company Kvantify completed the second close of a €7 million funding round in March 2026 to advance its hybrid quantum-classical approach to molecular simulation and commercialization of its quantum chemistry software stack. The company is also participating in the ODAQS Project, a research collaboration led by Aarhus University and supported by Innovation Fund Denmark that brings together researchers from Aarhus and Aalborg Universities to develop quantum software tools using reinforcement learning for drug discovery applications.Quantum ZeitgeistKvantify Secures €7M in Funding to Advance Quantum Drug DiscoveryKvantify, a Danish quantum computing company founded in 2022, has secured €7 million in a funding round extension from the European Innovation Council Fund and Delphinus Venture Capital to advance its quantum-enhanced drug discovery technology. The investment will support expansion of the company's Qrunch platform, launched in November 2025, which enables quantum chemistry simulations on existing quantum computers to address limitations in molecular modeling for drug development. The funding is intended to broaden market presence, establish collaborative partnerships with drug discovery organizations, and accelerate integration of quantum computing into pharmaceutical research workflows.HpcwireSince 1987 – Covering the Fastest Computers in the World and the People Who Run ThemKvantify announced the successful second close of its €7 million funding round, with investment from European Innovation Council Fund (EIC) and Danish-based Delphinus Venture Capital. The funding will support the company's mission to transform molecular discovery by coupling quantum and classical computing, building on the November 2025 launch of Qrunch, a technology for running quantum chemistry on real quantum computers. The investors expressed confidence in Kvantify's potential to accelerate drug discovery and strengthen Europe's position in quantum technology.ThequantuminsiderKvantify Partners with Danish Universities on Quantum Drug Discovery ProjectKvantify has partnered with Aarhus University and Aalborg University on the ODAQS project, which has received DKK 17.4 million in funding from Innovation Fund Denmark to advance quantum computing applications in drug discovery. The four-year project aims to develop quantum software that reduces technical barriers, enabling researchers and companies to focus on scientific problems rather than hardware limitations. The collaboration seeks to strengthen Denmark's quantum ecosystem while accelerating quantum computing adoption in life sciences.Quantum Computing ReportKvantify Secures €7M ($8.1M USD) Total Funding to Scale Quantum Drug Discovery PlatformKvantify has completed a second close of its funding round, bringing total raised to €7 million ($8.1 million USD), with participation from the European Innovation Council Fund and Delphinus Venture Capital. The funding will accelerate commercialization of Qrunch, the company's hybrid quantum-classical software platform launched in November 2025, designed to help pharmaceutical researchers solve complex molecular simulation problems beyond the reach of classical supercomputers. The investment positions Kvantify, founded in 2022, as a bridge between maturing quantum hardware and the life science industry while supporting European leadership in deep-tech innovation.